For years, science has attributed overeating and obesity to psychological factors- a failure of will power, poor discipline or traumatic childhood experiences. But current scientific research leads away from psychiatric explanations and toward biochemical, physiological and genetic explanations.
After more than 20 years of research, scientists have recently noted a connection between the role of the brain in eating behavior and food cravings. Research suggests that the brain's "reward cascade"--along with a healthy lifestyle of proper diet and exercise--plays a critical role in appetite control. The reward cascade is your body's chemical pathway for pleasure and satisfaction. It can affect the way you feel about yourself, the way you behave and the foods you choose to eat. Based on this cutting-edge, neuronutrient science, Anti-Craving Formula is formulated to help you control your urge to indulge in food. When used as part of a healthy diet and exercise program, it helps you lose weight and maintain the loss. By maintaining healthy levels of neurotransmitters in the brain, Anti-Craving Formula helps control your appetite so you can achieve your goal. Anti-Craving Formula does not contain stimulants. Its patented formula includes important vitamins, minerals and amino acids, including DL- phenylalanine, to help control your appetite and facilitate weight loss.*
Unlike virtually every weight loss product and plan, Anti-Craving Formula supports activity in your brain -- where hunger and cravings start. Most other products attempt to suppress your appetite after your brain has already signaled your body that you're hungry or craving a certain food.*
Research Brief
Why do you feel good some days and anxious others? Why do you crave carbohydrates or sweets when you're really not hungry? The answer: brain chemistry.
Feelings of well-being begin in the brain when it produces a chemical called serotonin, often called the "feel good hormone." Serotonin and other chemicals including endorphins, GABA and dopamine form the biological process known as the "reward cascade," which, as the name implies, controls feelings of well-being.
This complex chemical pathway can be affected by the foods that we eat. Consuming large amounts of carbohydrates affects pathways that positively reinforce the reward system, which explains why eating sweets makes us feel good.
New research suggests that specific nutrients can positively influence the reward cascade by maintaining healthy levels of neurotransmitters in the brain, thus helping to control your cravings.
FAQs
Q: When should I take Anti-Craving Formula?
A: It is important to follow the directions carefully. For best results, take Anti-Craving Formula 30-60 minutes before each meal and each serving of Bios Life 2® Natural.
Q: I have a slow metabolism. Will this product work for me?
A: This product provides ingredients that help support natural carbohydrate and fat metabolism. It does not speed up your basal metabolism, but it may help you metabolize certain nutrients more efficiently.*
Q: Are there any stimulants, such as ephedra, in this product?
A: No. This product does not contain any stimulants.
Q: How fast can I expect to lose weight?
A: This product has a "building" effect in the body, so it may take approximately six to eight weeks until you start seeing effects. However, results will vary from person to person and will depend on your diet and exercise habits.
Q: Why do we use polynicotinate versus picolinate for our chromium?
A: Studies suggest that polynicotinate is the more biologically active form of chromium.
Q: Can I become addicted to any of the ingredients in this product?
A: No. This formula is nonaddictive.
References
Beckmann H., et al. DL-phenylalanine as an antidepressant. Open study. Arzneimittelforschung. 1978;28(8):1283-4. German. [DL-phenylalanine]
Blum K., et al. Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB). Mol. Psychiatry. 1997 May;2(3):239-46. [Proprietary Blend]
Blum K., et al. Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics. 1996 Aug.;6(4):297-305. [Proprietary Blend]
Blum K., et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J. R. Soc. Med. 1996 Jul.;89(7):396-400. Review. [Proprietary Blend] |
